Norverapamil hydrochloride

CAS No. 67812-42-4

Norverapamil hydrochloride( ±)-Norverapamil hydrochloride | D591 hydrochloride )

Catalog No. M15590 CAS No. 67812-42-4

A calcium channel blocker and the main active metabolite of verapamil.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 69 Get Quote
5MG 105 Get Quote
10MG 177 Get Quote
25MG 406 Get Quote
50MG 597 Get Quote
100MG 843 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Norverapamil hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A calcium channel blocker and the main active metabolite of verapamil.
  • Description
    A calcium channel blocker and the main active metabolite of verapamil.
  • In Vitro
    Norverapamil hydrochloride ((±)-Norverapamil hydrochloride) is similarly effective as verapamil at inhibiting isoniazid and rifampicin tolerance and killing of intracellular M. tuberculosis in the absence of other drugs. norverapamil, also inhibits macrophage-induced tolerance and achieves similar serum levels to verapamil. Verapamil and its major metabolite norverapamil were identified to be both mechanism-based inhibitors and substrates of CYP3A and reported to have non-linear pharmacokinetics in clinic.
  • In Vivo
    Norverapamil hydrochloride (9 mg/kg; p.o.), a major metabolite of verapamil, has terminal half-life, AUC and Cmax values of 9.4 hours, 260 ng?h/ml, and 41.6 ng/mL, respectively. Animal Model:Male Sprague-Dawley rats Dosage:9 mg/kg (Pharmacokinetic Study)Administration:Oral administration Result:t1/2=9.4 hours;AUC=260 ng?h/mL;Cmax=41.6 ng/mL.
  • Synonyms
    ±)-Norverapamil hydrochloride | D591 hydrochloride
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    67812-42-4
  • Formula Weight
    477.036
  • Molecular Formula
    C26H37ClN2O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 31 mg/mL
  • SMILES
    N#CC(C(C)C)(C1=CC=C(OC)C(OC)=C1)CCCNCCC2=CC=C(OC)C(OC)=C2.[H]Cl
  • Chemical Name
    Benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-, hydrochloride (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee YS, et al. Xenobiotica. 2012 Aug;42(8):766-74. 2. Adams KN, et al. J Infect Dis. 2014 Aug 1;210(3):456-66. 3. Sawicki W. Eur J Pharm Biopharm. 2002 Jan;53(1):29-35.
molnova catalog
related products
  • (S)-crizotinib

    (S)-crizotinib(IC50 of 72 nM), an effective MTH1 (NUDT1) inhibitor, is the (S)-enantiomer of crizotinib.

  • Cinacalcet metabolit...

    Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.

  • SR33805

    SR33805 is a potent antagonist of Ca2+ channel(EC50s of 4.1 nM and 33 nM in depolarized and polarized conditions, respectively)Acute treatment with SR33805 restored the MI-altered cell shortening without affecting the Ca(2+) transient amplitude, suggesting an increase of myofilament Ca(2+) sensitivity in MI myocytes.?